Metrikler
Yayın
151
Açık Erişim
17
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1995 - 2002
1995 - 2002Doktora
Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü, Türkiye
1995 - 2002
1995 - 2002Doktora
Université Paris XI, Eczacılık Fakültesi, Farmasötik Teknoloji, Fransa
1992 - 1995
1992 - 1995Yüksek Lisans
Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü, Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
B2 Orta Üstü
B2 Orta ÜstüFransızca
A2 Temel
A2 TemelFlemenkçe
Araştırma Alanları
Eczacılık
Eczacılık Teknolojisi
Farmasötik Teknoloji
Sağlık Bilimleri
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2013 - Devam Ediyor
2013 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü
Yönetimsel Görevler
2022 - Devam Ediyor
2022 - Devam EdiyorAnabilim/Bilim Dalı Başkanı
Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü
2010 - 2013
2010 - 2013Dekan Yardımcısı
Hacettepe Üniversitesi, Eczacılık Fakültesi
Yönetilen Tezler
2018
2018Doktora
POLİKATYONİK AMFİFİLİK SİKLODEKSTRİN NANOPARTİKÜLLERİN ANTİKANSER İLAÇ TAŞIYICI SİSTEM OLARAK ETKİNLİK VE GÜVENLİK AÇISINDAN DEĞERLENDİRİLMESİ
BİLENSOY E.
G.VARAN(Öğrenci)
2017
2017Doktora
HPV-İlişkili Servikal Kanserin Tedavisine Yönelik İlaç Yüklü Nanopartikül Formülasyonlarının Printing Teknolojisi ile Hazırlanması ve Karakterizasyonu
BİLENSOY E.
C.VARAN(Öğrenci)
2016
2016Doktora
Antikanser ilaç dosetakselin anyonik ve katyonik polimerik nanokapsüllerle formülasyonu ve oral uygulama sonrası etkinliğinin değerlendirilmesi
BİLENSOY E.
D.DAŞKIN(Öğrenci)
2015
2015Doktora
Tumor specific delivery and in vitro-in vivo evaluation of paclitaxel loaded folate-conjugated amphiphilic cyclodextrin nanoparticles
BİLENSOY E.
N.ERDOĞAR(Öğrenci)
2014
2014Doktora
Formulatıon and antıcancer effıcacy evaluatıon of polymerıc and cyclodextrın nanocapsules desıgned for oral applıcatıon
BİLENSOY E.
H.ÜNAL(Öğrenci)
2013
2013Yüksek Lisans
Meme kanseri tedavisinde paklitaksel yüklü polikatyonik ve anyonik siklodekstrin nanoküre formülasyonu ve in vitro değerlendirilmesi
BİLENSOY E.
G.IŞIK(Öğrenci)
2013
2013Yüksek Lisans
Beyin glioma tedavisinde dosetaksel yüklü katyonik nanopartiküllerin tasarımı ve in vitro değerlendirilmesi
BİLENSOY E.
C.VARAN(Öğrenci)
2011
2011Yüksek Lisans
Mesane tümörlerinin intravezikal kemoterapisi için tasarlanmış Mitomisin C yüklü katyonik nanopartiküllerin in vitro-in vivo değerlendirilmesi
BİLENSOY E.
N.ERDOĞAR(Öğrenci)
2009
2009Doktora
Kamptotesin içeren polimerik ve oligosakkarit bazlı nanopartiküler formülasyonların geliştirilmesi ve in vitro-in vivo değerlendirilmesi
ÇALIŞ S., BİLENSOY E.
Y.ÇIRPANLI(Öğrenci)
2009
2009Yüksek Lisans
Siklodekstrin kompleksi oluşturarak, ekzemestanın çözünmesinin ve in vitro geçirgenliğinin arttırılması.
BİLENSOY E.
B.YAVUZ(Öğrenci)
Makaleler
Tümü (92)
SCI-E, SSCI, AHCI (83)
SCI-E, SSCI, AHCI, ESCI (85)
ESCI (1)
Scopus (82)
TRDizin (3)
Diğer Yayınlar (3)
2025
20251. A novel injectable nanotherapeutic platform increasing the bioavailability and anti-tumor efficacy of Arachidonylcyclopropylamide on an ectopic non-small cell lung cancer xenograft model: A randomized controlled trial
Boyacioglu O., VARAN C., BİLENSOY E., Aykut Z. G., REÇBER T., NEMUTLU E., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, 2025 (SCI-Expanded, Scopus)
2024
20242. 2-AG-loaded and bone marrow-targeted PCL nanoparticles as nanoplatforms for hematopoietic cell line mobilization
KÖSE S., VARAN C., Onen S., NEMUTLU E., BİLENSOY E., Korkusuz P.
STEM CELL RESEARCH & THERAPY
, cilt.15, sa.1, 2024 (SCI-Expanded, Scopus)
2024
20243. Optimization and characterization of Rituximab targeted multidrug loaded cyclodextrin nanoparticles against Non-Hodgkin Lymphoma
Demirturk N., VARAN G., KAĞA S., Malanga M., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.662, 2024 (SCI-Expanded, Scopus)
2024
20244. Cyclodextrin polymers containing ionizable and ionic groups: A comprehensive review from classifications and synthesis methods to applications
Kashani E., Maghsoudi S., Rezania H., Yarazavi M., Hajiabbas M., Benkovics G., et al.
MATERIALS TODAY CHEMISTRY
, cilt.39, 2024 (SCI-Expanded, Scopus)
2024
20245. Open forum conference on the ICH M13A bioequivalence guideline
Blume H., Wedemeyer S., Seidlitz A., Beuerle G., Klein S., BİLENSOY E.
European Journal of Pharmaceutical Sciences
, cilt.196, 2024 (SCI-Expanded, Scopus)
2023
20236. Design and Characterization of Carboplatin and Paclitaxel Loaded PCL Filaments for 3D Printed Controlled Release Intrauterine Implants
Varan C., Aksüt D., Şen M., Bilensoy E.
PHARMACEUTICS
, cilt.15, sa.4, ss.1-17, 2023 (SCI-Expanded, Scopus)
2023
20237. Oral docetaxel delivery with cationic polymeric core-shell nanocapsules: In vitro and in vivo evaluation
Daşkın D., Erdoğar N., İSKİT A. B., BİLENSOY E.
Journal of Drug Delivery Science and Technology
, cilt.80, 2023 (SCI-Expanded, Scopus)
2023
20238. Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines
Şenol Y., KAPLAN O., VARAN C., Demirtürk N., Öncül S., Fidan B. B., et al.
Journal of Drug Delivery Science and Technology
, cilt.79, 2023 (SCI-Expanded, Scopus)
2023
20239. Is there a niche for zinc oxide nanoparticles in future drug discovery?
BİLENSOY E., VARAN C.
Expert Opinion on Drug Discovery
, cilt.18, sa.9, ss.943-945, 2023 (SCI-Expanded, Scopus)
2023
202310. Insight into oral amphiphilic cyclodextrin nanoparticles for colorectal cancer: comprehensive mathematical model of drug release kinetic studies and antitumoral efficacy in 3D spheroid colon tumors
ÜNAL S., VARAN G., Benito J. M., AKTAŞ Y., BİLENSOY E.
Beilstein Journal of Organic Chemistry
, cilt.19, ss.139-157, 2023 (SCI-Expanded, Scopus)
2022
202211. Nanocarriers targeting the diseases of the pancreas
Demirturk N., BİLENSOY E.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
, cilt.170, ss.10-23, 2022 (SCI-Expanded, Scopus)
2021
202112. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model
Unal S., ÖZTÜRK S. C., BİLGİÇ E., Yanik H., KORKUSUZ P., AKTAŞ Y., et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
, cilt.169, ss.168-177, 2021 (SCI-Expanded, Scopus)
2021
202113. Q-tof lc/ms-based untargeted metabolomics approach to evaluate the effect of folate-conjugated cyclodextrins on triple-negative breast cancer cells
Varol I., KAPLAN O., Erdoğar N., Öncül S., Nielsen T. T., ERCAN A., et al.
Current Pharmaceutical Analysis
, cilt.17, sa.10, ss.1272-1281, 2021 (SCI-Expanded, Scopus)
2021
202114. A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers
Akkin S., VARAN G., BİLENSOY E.
MOLECULES
, cilt.26, sa.11, 2021 (SCI-Expanded, Scopus)
2021
202115. Development of oral aprepitant-loaded chitosan-polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation
Erdogar N., Akkin S., Nielsen T. T., Ozcelebi E., Erdogdu B., NEMUTLU E., et al.
JOURNAL OF PHARMACEUTICAL INVESTIGATION
, cilt.51, sa.3, ss.297-310, 2021 (SCI-Expanded, Scopus)
2021
202116. Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver
Varan G., Demirturk N., Benito J. M., BİLENSOY E.
Journal of Drug Targeting
, cilt.29, sa.4, ss.439-453, 2021 (SCI-Expanded, Scopus)
2021
202117. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level
ERCAN A., ÇELEBİER M., ÖNCÜL S., VARAN G., KOÇAK E., Benito J. M., et al.
International Journal of Pharmaceutics
, cilt.598, 2021 (SCI-Expanded, Scopus)
2021
202118. Determination and validation of aprepitant in rat plasma using LC-MS/MS.
Erdogar N., REÇBER T., B Iskit A. B., BİLENSOY E., KIR S., NEMUTLU E.
Bioanalysis
, cilt.13, sa.5, ss.363-372, 2021 (SCI-Expanded, Scopus)
2021
202119. Therapeutic efficacy and biodistribution of paclitaxel-bound amphiphilic cyclodextrin nanoparticles: Analyses in 3D tumor culture and tumor-bearing animals in vivo
Varan G., Varan C., Öztürk S. C., Benito J. M., Esendağlı G., Bilensoy E.
Nanomaterials
, cilt.11, sa.2, ss.1-18, 2021 (SCI-Expanded, Scopus)
2021
202120. ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro.
Boyacioglu O., BİLGİÇ E., VARAN C., BİLENSOY E., NEMUTLU E., GÜLMEZ SEVİM D., et al.
Cell death & disease
, cilt.12, sa.1, ss.56, 2021 (SCI-Expanded, Scopus)
2021
202121. Erlotinib complexation with randomly methylated beta-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer
Erdogar N., Akkin S., VARAN G., BİLENSOY E.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
, cilt.26, ss.797-806, 2021 (SCI-Expanded, Scopus)
2021
202122. Printers and Printing Technologies in the Pharmaceutical Field Yazıcılar ve Baskı Teknolojilerinin Farmasötik Alanda Kullanımı
Çobanoğlu E., VARAN C., BİLENSOY E.
Fabad Journal of Pharmaceutical Sciences
, cilt.46, sa.1, ss.43-78, 2021 (Scopus)
2020
202023. Preparation and characterization of cyclodextrin nanosponges for organic toxic molecule removal
VARAN C., Anceschi A., Sevli S., Bruni N., Giraudo L., BİLGİÇ E., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.585, 2020 (SCI-Expanded, Scopus)
2020
202024. Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization
ÜNAL S., AKTAŞ Y., Benito J. M., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.584, 2020 (SCI-Expanded, Scopus)
2020
202025. Improved oral bioavailability of anticancer drug tamoxifen through complexation with water soluble cyclodextrins: in vitro and in vivo evaluation
Erdoğar N., NEMUTLU E., İSKİT A. B., KARA Ş. A., Teksin Z. Ş., BİLENSOY E.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY
, cilt.96, sa.1-2, ss.81-91, 2020 (SCI-Expanded, Scopus)
2019
201926. Mechanical characterization and ex vivo evaluation of anticancer and antiviral drug printed bioadhesive film for the treatment of cervical cancer
Varan C., Şen M., Sandler N., Aktaş Y., Bilensoy E.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
, cilt.130, ss.114-123, 2019 (SCI-Expanded, Scopus)
2019
201927. The effect of Quercus coccifera L. Extract on the Necrosis of Random-pattern Skin Flaps in Rats Quercus coccifera L. Ekstresinin Random Patern Deri Flebi Nekrozu Üzerine Etkisi
Orhan E., Aka İ. Ö., Yüzbaşıoğlu M., Yavuz B., BİLENSOY E., Uz A.
Haseki Tip Bulteni
, cilt.57, sa.3, ss.249-254, 2019 (Scopus, TRDizin)
2019
201928. Plant-Based Natural Polymeric Nanoparticles as Promising Carriers for Anticancer Therapeutics
Varan G., VARAN C., BİLENSOY E.
POLYMERIC NANOPARTICLES AS A PROMISING TOOL FOR ANTI-CANCER THERAPEUTICS
, ss.293-318, 2019 (SCI-Expanded)
2019
201929. Cyclodextrin-Based Nanosystems: Current Status and Future Prospects
VARAN C., Varan G., Erdogar N., BİLENSOY E.
DRUG DELIVERY NANOSYSTEMS: FROM BIOINSPIRATION AND BIOMIMETICS TO CLINICAL APPLICATIONS
, ss.29-58, 2019 (SCI-Expanded)
2018
201830. Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells
ERCAN A., ÇELEBİER M., VARAN G., ÖNCÜL S., Nenni M., KAPLAN O., et al.
European Journal of Pharmaceutical Sciences
, cilt.123, ss.377-386, 2018 (SCI-Expanded, Scopus)
2018
201831. The effect of Arnebia purpurea extract on the survival of random pattern skin flaps in rats
ORHAN A. E., YÜZBAŞIOĞLU M., EROL Y. R., BİLENSOY E., ERDOĞAR N., DEMİREZER L. Ö., et al.
The European Research Journal
, cilt.4, ss.152-156, 2018 (TRDizin)
2018
201832. Cellular interaction and tumoral penetration properties of cyclodextrin nanoparticles on 3D breast tumor model
Varan G., Patrulea V., Borchard G., BİLENSOY E.
Nanomaterials
, cilt.8, sa.2, 2018 (SCI-Expanded, Scopus)
2018
201833. Cyclodextrin-based polymeric nanosystems
Erdogar N., Varan G., VARAN C., BİLENSOY E.
DRUG TARGETING AND STIMULI SENSITIVE DRUG DELIVERY SYSTEMS
, ss.715-748, 2018 (SCI-Expanded)
2018
201834. Cyclodextrin-Based Nanosystems in Targeted Cancer Therapy
Erdogar N., BİLENSOY E.
CYCLODEXTRIN APPLICATIONS IN MEDICINE, FOOD, ENVIRONMENT AND LIQUID CRYSTALS
, cilt.17, ss.59-80, 2018 (SCI-Expanded)
2018
201835. Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer
ERDOĞAR N., ESENDAĞLI G., Nielsen T. T., Esendagli-Yilmaz G., Yoyen-Ermis D., Erdogdu B., et al.
JOURNAL OF DRUG TARGETING
, cilt.26, sa.1, ss.66-74, 2018 (SCI-Expanded, Scopus)
2018
201836. Nanocapsules for drug delivery: An updated review of the last decade
Erdoğar N., Akkin S., BİLENSOY E.
Recent Patents on Drug Delivery and Formulation
, cilt.12, sa.4, ss.252-266, 2018 (Scopus)
2017
201737. Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration
VARAN C., WİCKSTRÖM H., SANDLER N., AKTAŞ Y., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.531, sa.2, ss.701-713, 2017 (SCI-Expanded, Scopus)
2017
201738. Amphiphilic cyclodextrin nanoparticles
VARAN G., VARAN C., ERDOĞAR N., Hincal A. A., BİLENSOY E.
International Journal of Pharmaceutics
, cilt.531, sa.2, ss.457-469, 2017 (SCI-Expanded, Scopus)
2017
201739. Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment
VARAN C., BİLENSOY E.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY
, cilt.8, ss.1446-1456, 2017 (SCI-Expanded, Scopus)
2017
201740. Amphiphilic cyclodextrin derivatives for targeted drug delivery to tumors
ERDOĞAR N., VARAN G., BİLENSOY E.
Current Topics in Medicinal Chemistry
, cilt.17, sa.13, ss.1521-1528, 2017 (SCI-Expanded, Scopus)
2017
201741. Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery
Varan G., Benito J. M., Mellet C. O., BİLENSOY E.
Beilstein Journal of Nanotechnology
, cilt.8, sa.1, ss.1457-1468, 2017 (SCI-Expanded, Scopus)
2017
201742. An Improved and Validated HPLC Method for the Determination of Methylprednisolone Sodium Succinate and its Degradation Products in Nanoparticles
KARABEY-AKYUREK Y., NEMUTLU E., BİLENSOY E., ÖNER L.
CURRENT PHARMACEUTICAL ANALYSIS
, cilt.13, sa.2, ss.162-168, 2017 (SCI-Expanded, Scopus)
2017
201743. Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model
KARABEY-AKYUREK Y., GURCAY A. G., GURCAN O., TURKOGLU O. F., Yabanoglu-Ciftci S., EROĞLU H., et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
, cilt.22, sa.8, ss.972-981, 2017 (SCI-Expanded, Scopus)
2016
201644. Cholesterol-Targeted Anticancer and Apoptotic Effects of Anionic and Polycationic Amphiphilic Cyclodextrin Nanoparticles
VARAN G., ÖNCÜL S., ERCAN A., BENITO J. M., MELLET C. O., BİLENSOY E.
Journal of Pharmaceutical Sciences
, cilt.105, sa.10, ss.3172-3182, 2016 (SCI-Expanded, Scopus)
2016
201645. Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles
ERDOĞAR N., ESENDAĞLI G., Nielsen T. T., ŞEN M., ÖNER L., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.509, ss.375-390, 2016 (SCI-Expanded, Scopus)
2016
201646. Siklodekstrinler ve Biyomedikal AlandakiUygulamaları
ÇELEN N., BİLENSOY E., ÇALIŞ S.
Hacettepe University Journal of the Faculty Pharmacy , 2016 (Hakemli Dergi)
2016
201647. Cyclodextrins and their applications in biomedical field Siklodekstrinler ve Biyomedikal Alandaki Uygulamaları
Çelen N., BİLENSOY E., ÇALIŞ S.
Hacettepe University Journal of the Faculty of Pharmacy
, cilt.36, sa.1, ss.50-69, 2016 (Scopus)
2015
201548. Amphiphilic cyclodextrins as enabling excipients for drug delivery and for decades of scientific collaboration: Tribute to a distinguished scientist, French representative and friend - A historical perspective
AKTAŞ Y., Yenice I., BİLENSOY E., HINCAL A. A.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, cilt.30, ss.261-265, 2015 (SCI-Expanded, Scopus)
2015
201549. Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model
ERDOĞAR N., İSKİT A. B., EROĞLU H., SARGON M. F., Mungan N. A., BİLENSOY E.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
, cilt.15, sa.12, ss.10156-10164, 2015 (SCI-Expanded, Scopus)
2015
201550. Role of Nanoparticles in the Treatment of Noninvasive Bladder Cancer
BİLENSOY E., Erdogar N., Mungan A. N.
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
, cilt.14, sa.1, ss.61-66, 2015 (ESCI, TRDizin)
2015
201551. Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin
UNAL H., Ozturk N., BİLENSOY E.
Beilstein Journal of Organic Chemistry
, cilt.11, ss.204-212, 2015 (SCI-Expanded, Scopus)
2015
201552. Core-shell hybrid nanocapsules for oral delivery of camptothecin: formulation development, in vitro and in vivo evaluation
UNAL H., D'ANGELO I., PAGANO E., BORRELLI F., IZZO A., UNGARO F., et al.
JOURNAL OF NANOPARTICLE RESEARCH
, cilt.17, sa.1, 2015 (SCI-Expanded, Scopus)
2015
201553. Cationic polymer nanoparticles for drug and gene delivery
BİLENSOY E., Işik G., VARAN C.
RSC Polymer Chemistry Series
, sa.13, ss.268-295, 2015 (SCI-Expanded)
2015
201554. Amphiphilic Cyclodextrin Nanoparticles for Effective and Safe Delivery of Anticancer Drugs
Bilensoy E.
GENEDIS 2014: NEURODEGENERATION
, cilt.822, ss.201, 2015 (SCI-Expanded, Scopus)
2014
201455. Binary, ternary and microencapsulated celecoxib complexes with beta-cyclodextrin formulated via hydrophilic polymers
Vranic E., Grizic D., Planinsek O., Srcic S., BİLENSOY E.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY
, cilt.80, ss.139-146, 2014 (SCI-Expanded, Scopus)
2014
201456. Development of implantable hydroxypropyl-beta-cyclodextrin coated polycaprolactone nanoparticles for the controlled delivery of docetaxel to solid tumors
VARAN C., BİLENSOY E.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY
, cilt.80, ss.9-15, 2014 (SCI-Expanded, Scopus)
2014
201457. Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: Safety and efficacy
ERDOĞAR N., İSKİT A. B., EROĞLU H., SARGON M. F., Mungan N. A., BİLENSOY E.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.471, ss.1-9, 2014 (SCI-Expanded, Scopus)
2012
201258. Wound healing activity of the Bellis perennis L. (common daisy)
Karakas F. P., Karakas A., Boran C., Turker A. U., YALÇIN F. N., BİLENSOY E.
NEW BIOTECHNOLOGY
, cilt.29, 2012 (SCI-Expanded, Scopus)
2012
201259. Prolonged retention and in vivo evaluation of cationic nanoparticles loaded with Mitomycin C designed for intravesical chemotherapy of bladder tumours
Erdogar N., İSKİT A. B., Mungan N. A., BİLENSOY E.
Journal of Microencapsulation
, cilt.29, sa.6, ss.576-582, 2012 (SCI-Expanded, Scopus)
2012
201260. The evaluation of topical administration of Bellis perennis fraction on circular excision wound healing in Wistar albino rats
Karakaş F. P., Karakaş A., Boran Ç., Türker A. U., YALÇIN F. N., BİLENSOY E.
Pharmaceutical Biology
, cilt.50, sa.8, ss.1031-1037, 2012 (SCI-Expanded, Scopus)
2011
201161. Rapamycin-cyclodextrin complexation: Improved solubility and dissolution rate
Abdur Rouf M., VURAL İ., BİLENSOY E., Hincal A., Erol D. D.
Journal of Inclusion Phenomena and Macrocyclic Chemistry
, cilt.70, ss.167-175, 2011 (SCI-Expanded)
2011
201162. Preface
BİLENSOY E.
Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications
, 2011 (SCI-Expanded)
2011
201163. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model
Çirpanli Y., Allard E., Passirani C., Bilensoy E., Lemaire L., Çaliş S., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.403, ss.201-206, 2011 (SCI-Expanded, Scopus)
2011
201164. A double-blind placebo-controlled study of 5-fluorouracil: Cyclodextrin complex loaded thermosensitive gel for the treatment of HPV induced condyloma
BİLENSOY E., Moroy P., Çırpanlı Y., Bilensoy T., ÇALIŞ S., Mollamahmutoglu L.
Journal of Inclusion Phenomena and Macrocyclic Chemistry
, cilt.69, ss.309-313, 2011 (SCI-Expanded)
2010
201065. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(ε-caprolactone) and chitosan nanoparticles
Cirpanli Y., Yerlikaya F., Ozturk K., Erdogar N., Launay M., Gegu C., et al.
Pharmazie
, cilt.65, sa.12, ss.867-870, 2010 (SCI-Expanded, Scopus)
2010
201066. An alternative cyclodextrin based formulation for oral anticancer drug exemestane: In vitro and cell culture studies.
Yavuz B., Sarisözen C., Vural İ., Bilensoy E., Sumnu M.
Journal of controlled release : official journal of the Controlled Release Society
, cilt.148, sa.1, 2010 (SCI-Expanded, Scopus)
2010
201067. Preparation and characterization of cationic nanoparticles loaded with Mitomycin C by double emulsion and ionotropic gelation techniques.
Erdoǧar N., Mungan A., Bilensoy E.
Journal of controlled release : official journal of the Controlled Release Society
, cilt.148, sa.1, 2010 (SCI-Expanded, Scopus)
2010
201068. Alternative oral exemestane formulation: Improved dissolution and permeation
Yavuz B., BİLENSOY E., VURAL İ., Sumnu M.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.398, ss.137-145, 2010 (SCI-Expanded, Scopus)
2010
201069. Development of polymeric and cyclodextrin nanoparticles for camptothecin delivery.
Cirpanli Y., Bilensoy E., Dogan A. L., Calis S.
Journal of controlled release : official journal of the Controlled Release Society
, cilt.148, sa.1, 2010 (SCI-Expanded, Scopus)
2010
201070. Cationic nanoparticles for cancer therapy
BİLENSOY E.
Expert Opinion on Drug Delivery
, cilt.7, sa.7, ss.795-809, 2010 (SCI-Expanded, Scopus)
2009
200971. Antibacterial activity of triclosan chitosan coated graft on hernia graft infection model
Çakmak A., Çirpanli Y., Bilensoy E., Yorganci K., Çaliş S., Saribaş Z., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.381, sa.2, ss.214-219, 2009 (SCI-Expanded, Scopus)
2009
200972. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles
BİLENSOY E., Hincal A. A.
Expert Opinion on Drug Delivery
, cilt.6, sa.11, ss.1161-1173, 2009 (SCI-Expanded, Scopus)
2009
200973. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF TAMOXIFEN CITRATE USING NORMAL PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Yerlikaya F., Launay M., Gegu C., Leturgez T., BİLENSOY E., ÇALIŞ S., et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
, cilt.38, sa.1, ss.183-184, 2009 (SCI-Expanded)
2009
200974. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery
Çirpanli Y., Bilensoy E., Lale Doǧan A., Çaliş S.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
, cilt.73, sa.1, ss.82-89, 2009 (SCI-Expanded, Scopus)
2009
200975. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors
Bilensoy E., Sarisozen C., Esendagli G., Doğan A., Aktas Y., Şen M., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.371, ss.170-176, 2009 (SCI-Expanded, Scopus)
2008
200876. Hyaluronic acid coated poly-ε-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea
Yenice I., Mocan M. C., PALASKA E., Bochot A., BİLENSOY E., VURAL İ., et al.
Experimental Eye Research
, cilt.87, sa.3, ss.162-167, 2008 (SCI-Expanded, Scopus)
2008
200877. Nanoparticulate delivery systems based on amphiphilic cyclodextrins
BİLENSOY E.
Journal of Biomedical Nanotechnology
, cilt.4, sa.3, ss.293-303, 2008 (SCI-Expanded, Scopus)
2008
200878. Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel
Bilensoy E., Gurkaynak O., Ertan M., Şen M., Hincal A. A.
JOURNAL OF PHARMACEUTICAL SCIENCES
, cilt.97, ss.1519-1529, 2008 (SCI-Expanded, Scopus)
2008
200879. Safety and efficacy of amphiphilic ß-cyclodextrin nanoparticles for paclitaxel delivery
BİLENSOY E., Gürkaynak O., DOĞAN A., Hincal A. A.
International Journal of Pharmaceutics
, cilt.347, ss.163-170, 2008 (SCI-Expanded, Scopus)
2007
200780. Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: cyclodextrin complex for HPV-induced cervical cancer
Bilensoy E., Cirpanli Y., Sen M., Dogan A. L., Calis S.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY
, cilt.57, ss.363-370, 2007 (SCI-Expanded, Scopus)
2007
200781. Bioavailability File: Exemestane
YAVUZ B., BİLENSOY E., Sumnu M.
FABAD J. Pharm. Sci. , cilt.32, sa.2, ss.79-89, 2007 (Hakemli Dergi)
2007
200782. Complexation behavior of antiestrogen drug tamoxifen citrate with natural and modified beta-cyclodextrins
Bilensoy E., Dogan L., Sen M., Hincal A.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY
, cilt.57, ss.651-655, 2007 (SCI-Expanded, Scopus)
2007
200783. Analytical Method Validation for HPLC Assay of Oral Anticancer Drug Exemestane
YAVUZ B., BİLENSOY E., Sumnu M.
FABAD J. Pharm. Sci , cilt.32, sa.1, ss.15-22, 2007 (Hakemli Dergi)
2006
200684. Cytotoxic evaluation of injectable cyclodextrin nanoparticles
Memisoglu-Bilensoy E., DOĞAN A., Hincal A. A.
Journal of Pharmacy and Pharmacology
, cilt.58, sa.5, ss.585-589, 2006 (SCI-Expanded, Scopus)
2006
200685. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex
Bilensoy E., Rouf M. A., Vural İ., Sen M., Hincal A. A.
AAPS PharmSciTech
, cilt.7, sa.2, 2006 (SCI-Expanded, Scopus)
2006
200686. Sterile, injectable cyclodextrin nanoparticles: Effects of gamma irradiation and autoclaving
Memisoglu-Bilensoy E., Hincal A. A.
International Journal of Pharmaceutics
, cilt.311, ss.203-208, 2006 (SCI-Expanded, Scopus)
2006
200687. Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules
Memisoglu-Bilensoy E., Sen M., Hincal A. A.
Journal of Microencapsulation
, cilt.23, sa.1, ss.59-68, 2006 (SCI-Expanded, Scopus)
2006
200688. Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin.
BİLENSOY E., Rouf M., VURAL İ., Hincal A.
Journal of controlled release : official journal of the Controlled Release Society
, cilt.116, sa.2, 2006 (SCI-Expanded, Scopus)
2005
200589. Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: In vitro characterization and cytotoxicity
Memisoglu-Bilensoy E., VURAL İ., Bochot A., Renoir J. M., Duchene D., Hincal A. A.
Journal of Controlled Release
, cilt.104, sa.3, ss.489-496, 2005 (SCI-Expanded, Scopus)
2005
200590. Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: System development and evaluation
Memisoglu-Bilensoy E.
European Journal of Pharmaceutical Sciences
, cilt.25, 2005 (SCI-Expanded, Scopus)
2005
200591. Transcription efficiency of tamoxifen citrate-loaded β-cyclodextrin nanoparticles
VURAL İ., Memisoglu-Bilensoy E., Renoir J., Bochot A., Duchêne D., Hincal A.
Journal of Drug Delivery Science and Technology
, cilt.15, sa.5, ss.339-342, 2005 (SCI-Expanded, Scopus)
2002
200292. Amphiphilic beta-cyclodextrins modified on the primary face: Synthesis, characterization, and evaluation of their potential as novel excipients in the preparation of nanocapsules
Memisoglu E., Bochot A., Sen M., Charon D., Duchene D., Hincal A.
JOURNAL OF PHARMACEUTICAL SCIENCES
, cilt.91, sa.5, ss.1214-1224, 2002 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2021
20211. Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer
ERDOĞDU N., Akkın S., VARAN G., BİLENSOY E.
13th Internation symposium of Pharmaceutical Science, Ankara, Türkiye, 22 - 25 Haziran 2021, (Tam Metin Bildiri)
2019
20192. Farelerde Tamoksifen ve Majör Metaboliti N-Desmetil-Tamoksifen’in LC- MS/MS Yöntemiyle Tayini
ERDOĞAR N., NEMUTLU E., KIR S., İSKİT A. B., BİLENSOY E.
XVI. Ulusal Spektroskopi Kongresi, Türkiye, 7 - 09 Kasım 2019, (Tam Metin Bildiri)
2019
20193. Cannabinoid Receptor 1-Mediated Antiproliferative Effect of ACPA and ACPA-PCL Controlled Release System on Non-Small Cell Lung Cancer Lines
BOYACIOĞLU Ö., BİLGİÇ E., VARAN C., BİLENSOY E., NEMUTLU E., KARAOSMANOĞLU B., et al.
EACR Conference Nanotechnology in Cancer: Engineering for Oncology, Cambridge, Kanada, 12 - 14 Eylül 2019, (Özet Bildiri)
2019
20194. Development of a new antiproliferative arachydonoylcyclopropilamide (ACPA) releasing nanoparticle-based drug for endometrial cancers by targeting cannabinoid 1 receptors
BİLGİÇ E., BOYACIOĞLU Ö., VARAN C., BİLENSOY E., NEMUTLU E., KARAOSMANOĞLU B., et al.
EACR Conference Nanotechnology in Cancer: Engineering for Oncology, 12 - 14 Eylül 2019, (Özet Bildiri)
2019
20195. A Metabolomic Study to Investigate the Effect of Folate Conjugated Nanoparticles on Triple Negative Breast Cancer Cells
ERCAN A., ÇELEBİER M., varol ı., KAPLAN O., Varan G., ÖNCÜL S., et al.
EUFEPS Annual Meeting 2019 PERSONALIZED MEDICINES,TARGETED THERAPIES,PRECISION DRUG DELIVERY, 6 - 08 Mart 2019, (Tam Metin Bildiri)
2019
20196. Development and Characterization of Arachidonoylcyclopropilamide-Loaded Polycaprolactone Nanoparticle Drug Formulation
BOYACIOĞLU Ö., BİLGİÇ E., VARAN C., BİLENSOY E., NEMUTLU E., KORKUSUZ P.
24th International Biomedical Science Technology Symposium, 17 - 20 Ekim 2019, (Özet Bildiri)
2018
20187. The effect of polycationic amphiphilic cyclodestrin nanoparticles on mda-mb cancer cells: A metabolomic approach to understand the mechanism
ÇELEBİER M., KAPLAN O., VARAN G., ÖNCÜL S., KOÇAK E., ERCAN A., et al.
12 th International symposium on pharmaceutical sciences, 26 Haziran 2018, (Özet Bildiri)
2018
20188. GENOMIC AND METABOLOMIC STUDIES OF POLYCATIONIC AMPHIPHILIC CYCLODEXTRIN NANOPARTICLESON HEPG2 CELL LINE
ERCAN A., ÇELEBİER M., Varan G., ÖNCÜL S., KOÇAK E., KAPLAN O., et al.
EUFEPS Annual Meeting 2018 Crossing Barriers for Future Medicines, 24 - 26 Mayıs 2018, (Tam Metin Bildiri)
2018
20189. Mechanical Characterization and ex vivo Evaluation of Inkjet Printed Bioadhesive Film Formulation of Complexed Paclitaxel and Nanoparticulate Cidofovir
VARAN C., ŞEN M., SANDLER N., AKTAŞ Y., BİLENSOY E.
EUFEPS Annual Meeting 2018, Atina, Yunanistan, 24 - 26 Mayıs 2018, (Özet Bildiri)
2017
201710. Investigation of the Effect of Cyclodextrin Nanoparticles on MCF 7 Breast Cancer Cell Line by Proteomics Approaches
BİLENSOY E., ÇELEBİER M., ERCAN A., NENNİ M., IŞIK G., ÖNCÜL S., et al.
7th BBBB International Conference on Pharmaceutical Sciences, 5 - 07 Ekim 2017, (Tam Metin Bildiri)
2017
201711. Printing and characterization of antiviral and anticancer drug loaded film formulation by using inkjet printer
VARAN C., ŞEN M., SANDLER N., AKTAŞ Y., BİLENSOY E.
7th BBBB International Conference on Pharmaceutical Sciences, 5 - 07 Ekim 2017, (Özet Bildiri)
2017
201712. Anticancer and Antiviral Drug Printed Bioadhesive Film for Cervical Cancer:Ink Formulation Development by using Cyclodextrin Derivatives
VARAN C., SANDLER N., BİLENSOY E.
5th European Cyclodextrin Conference, 3 - 06 Ekim 2017, (Özet Bildiri)
2017
201713. Preparation and Characterization of Antiviral and Anticancer Drug Printed Film Formulations for the treatment of Cervical Cancer
VARAN C., ŞEN M., SANDLER N., BİLENSOY E.
SANKO University Innovation in Medicine Summit, 11 - 13 Mayıs 2017, (Özet Bildiri)
2017
201714. Evaluation of Cholesterol-Targeted Amphiphilic Cyclodextrin Nanoparticles for Cancer Therapy
VARAN G., ÖNCÜL S., ERCAN A., BENİTO J., MELLET C. O., BİLENSOY E.
Innovation in Medicine Meetings III Congress, 11 - 13 Mayıs 2017, (Özet Bildiri)
2017
201715. Novel Folate-Conjugated Amphiphilic Cyclodextrin Nanoparticles For Paclitaxel Delivery in Recurrent Metastatic Breast Cancer
ERDOĞAR N., ESENDAĞLI G., NIELSEN T. T., ESENDAĞLI YILMAZ G., SARGON M. F., ÖNER L., et al.
Innovation in Medicine Summit-3, 11 - 13 Mayıs 2017, (Özet Bildiri)
2015
201516. In Vitro and In Vivo Evaluation of Tumor Targeted Nanoparticles for Paclitaxel Delivery with Folate conjugated Amphiphilic Cyclodextrin Derivatives
ERDOĞAR N., TERNDRUP N., ÖNER L., ESENDAĞLI G., BİLENSOY E.
4th European Conference on Cyclodextrins (EUROCD 2015), 6 - 09 Ekim 2015, (Özet Bildiri)
2015
201517. Nanoparticulate Cidofovir and Paclitaxel Cyclodextrin Complex Combination in Ink Jet Printed Adhesive Film for HPV Infection
VARAN C., SANDLER N., BİLENSOY E.
4th European Conference on Cyclodextrins, 6 - 09 Ekim 2015, (Özet Bildiri)
2015
201518. Cefixime oral bioavailability improved by cyclodextrin inclusion complex In vitro in vivo evaluation
ÇELEN N., ÖZTÜRK N., BİLENSOY E., ÇALIŞ S.
4th European Conference on Cyclodextrins, 6 - 09 Ekim 2015, (Tam Metin Bildiri)
2015
201519. Effects Of Quercus coccifera on Viability of Random Pattern Skin Flaps in Rats
ORHAN A. E., ÖZKAYA AKA İ., YÜZBAŞIOĞLU M., BİLENSOY E., YAVUZ B., UZ A.
9th BAPRAS (Balkan Association of Plastic Reconstructive And Aesthetic Surgery) Congress, + Day Aesthetic Symposium Figures and Shapes in the Balkans, 17 - 20 Eylül 2015, ss.64, (Özet Bildiri)
2015
201520. Optimization by 32 Factorial Design of Tumor Targeted Nanoparticles for Paclitaxel Delivery with Folate conjugated Amphiphilic Cyclodextrin
ERDOĞAR N., ÖNER L., ESENDAĞLI G., NİELSEN T., BİLENSOY E.
EUFEPS Annual Meeting, 15 - 17 Haziran 2015
2015
201521. Preparation and characterization of Cidofovir and Paclitaxel loaded bioadhesive film for the treatment of HPV induced cervical cancer by printing technology
VARAN C., SANDLER N., AKTAŞ Y., BİLENSOY E.
EUFEPS Annual Meeting 2015, 15 - 17 Haziran 2015, (Özet Bildiri)
2014
201422. Docetaxel loaded hydroxypropyl B cyclodextrin polycaprolactone nanoparticles formulation development and in vitro characterization
VARAN C., BİLENSOY E.
17th International Pharmaceutical Technology Symposium, 8 - 10 Eylül 2014, (Özet Bildiri)
2013
201323. Development of Docetaxel loaded Hydroxypropyl-β-Cylodextrin Polycaprolactone Nanoparticles for The Treatment of Solid Tumors
VARAN C., BİLENSOY E.
3rd European Conference on Cyclodextrins, 2 - 04 Ekim 2013, (Özet Bildiri)
2012
201224. Docetaxel-loaded cationic core-shell polycaprolactone nanoparticles designed for rat glioma model
VARAN C., BİLENSOY E.
9th Central European Symposium on Pharmaceutical Technology: CESPT 2012, 20 - 22 Eylül 2012, (Özet Bildiri)
2012
201225. Docetaxel-loaded core-shell polycaprolactone nanoparticles: formulation development and characterization
VARAN C., BİLENSOY E.
16th International Pharmaceutical Technology Symposium, 10 - 12 Eylül 2012, (Özet Bildiri)
2012
201226. Polycaprolactone nanoparticles for rat glioma model: influence of formulation parameters on the particle size and zeta potential
VARAN C., BİLENSOY E.
8th Nanoscience and Nanotechnology Congress International Academy of Nanomedine 3rd World Congress, 25 - 29 Haziran 2012, (Özet Bildiri)
2012
201227. Core-shell polycaprolactone nanoparticles for rat glioma model: formulation development and characterization
VARAN C., BİLENSOY E.
CRS Nordic Chapter Meeting, 3 - 05 Haziran 2012, (Özet Bildiri)
2010
201028. Safety and Efficacy of Amphiphilic Cyclodextrins for Drug Delivery
Hincal A. A., EROĞLU H., BİLENSOY E.
9th International Meeting of the International-Society-for-the-Study-of-Xenobiotics(ISSX), İstanbul, Türkiye, 4 - 08 Eylül 2010, cilt.42, ss.12-13, (Özet Bildiri)
2007
200729. Inclusion complexation of rapamycin with beta-cyclodextrin to improve solubility and stability of the drug
Rouf M. A., Bilensoy E., Vural I., Hincal A. A.
2nd BBBB Conference on Pharmaceutical Sciences, Tartu, Estonya, 13 - 15 Eylül 2007, cilt.32, (Özet Bildiri)
2007
200730. Tumor targeted nanoparticles for cancer therapy
Bilensoy E.
2nd BBBB Conference on Pharmaceutical Sciences, Tartu, Estonya, 13 - 15 Eylül 2007, cilt.32, (Özet Bildiri)
2007
200731. Stabilization of camptothecin in PLGA nanoparticles
Cirpanli Y., Bilensoy E., Calis S., Hincal A. A.
2nd BBBB Conference on Pharmaceutical Sciences, Tartu, Estonya, 13 - 15 Eylül 2007, cilt.32, (Özet Bildiri)
2007
200732. Determination of stability of rapamycin following exposure to different conditions
Rouf M. A., Bilensoy E., Vural I., Hincal A. A.
2nd BBBB Conference on Pharmaceutical Sciences, Tartu, Estonya, 13 - 15 Eylül 2007, cilt.32, (Özet Bildiri)
2007
200733. Bioadhesive coated poly-epsilon-caprolactone nanoparticles loaded with Mitomycin C for the treatment of superficial bladder tumors
Sarisozen C., Aktas Y., Mungan A., Bilensoy E.
2nd BBBB Conference on Pharmaceutical Sciences, Tartu, Estonya, 13 - 15 Eylül 2007, cilt.32, (Özet Bildiri)
2006
200634. Formulation of poorly water soluble drugs with amphiphilic beta cyclodextrins
Hincal A., Bilensoy E.
18th Helsinki Drug Research, Helsinki, Finlandiya, 1 - 02 Haziran 2006, cilt.28, (Özet Bildiri)
2006
200635. Targeted nanoparticles for cancer therapy
Bilensoy E.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.35, (Özet Bildiri)
Kitaplar
2020
20201. Biodistribution of polymeric, polysaccharide and metallic nanoparticles
Erdoğdu N., Varan G., Varan C., Bilensoy E.
Characterization of Pharmaceutical Nano- and Microsystems, Peltonen Leena,Douroumis Dennis,Fahr Alfred,Siepmann Jurgen,Snowden Martin J., Editör, John Wiley & Sons, West Sussex, UK , Cambridge, ss.275-290, 2020
2019
20192. Cyclodextrin Based Nano-Systems: Current Status and Future Prospects
VARAN C., VARAN G., ERDOĞAR N., BİLENSOY E.
Drug Delivery Nanosystems: From Bioinspiration and Biomimetics to Clinical Applications, Pippa Natassa, Demetzos Costas, Pispas Stergios, Editör, Pan Stanford, ss.29-49, 2019
2019
20193. Plant based natural polymer (Guar gum, pectin, starch, cellulose, cyclodextrins) nanoparticles as promising tool for anticancer therapeutics
VARAN G., VARAN C., BİLENSOY E.
Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics, Prashant Kesharwani, Kishore M. Paknikar, Virendra Gajbhiye, Editör, Academic Press, 2019
2018
20184. Cyclodextrin-based polymeric nanosystems
ERDOĞAR N., VARAN G., VARAN C., BİLENSOY E.
Drug Targeting and Stimuli Sensitive Drug Delivery Systems, Alina M. Holban, Editör, William Andrew, ss.715-748, 2018
2018
20185. Dozaj Şekilleri
ÇAPAN Y., SAVAŞER A., KANTARCI A. G., KARATAŞ A., ARICA YEGİN B., HASÇİÇEK C., et al.
Türk Farmakopesi 2017-II, Dr. ALİ ALKAN, ERAY KAPLAN, OĞUZHAN KOYUNCU, SELİN ERGÜN AYAN, Editör, SAĞLIK BAKANLIĞI, Ankara, ss.969-1014, 2018
2018
20186. Cyclodextrin-Based Nanosystems in Targeted Cancer Therapy
ERDOĞAR N., BİLENSOY E.
Cyclodextrin Applications in Medicine, Food, Environment and Liquid Crystals, Gregorio Crini, Eric Lichtfouse, Sophie Fourmentin, Editör, Springer, Cham, ss.59-80, 2018
2015
20157. Cationic polymer nanoparticles for drug and gene delivery
BİLENSOY E., IŞIK G., VARAN C.
Cationic Polymers in Regenerative Medicine, Samal Sangram K., Dubruel Peter, Editör, Royal Society of Chemistry, 2015
Desteklenen Projeler
2023 - 2026
2023 - 2026Böbrek kanseri tedavisi için moleküler dinamik simülasyonlar kullanılarak rekombinant insan interlökin-2 içeren oral nano ilaç taşıyıcı sistemlerin geliştirilmesi ve in vitro - in vivo değerlendirilmesi
TÜBİTAK Projesi , 1001 - Bilimsel ve Teknolojik Araştırma Projelerini Destekleme Programı
Varan G., Bilensoy E., Olğaç A., Canpınar H., Teksin Z. Ş.(Yürütücü)
2023 - 2024
2023 - 2024NonHodgkin Lenfoma Tedavisinde İlaç Direncini Yenmek Amacıyla Aktif Hedeflendirilmiş Çoklu İlaç Yüklü Nanopartiküllerin Geliştirilmesi ve in vitro in vivo Etkinlik ve Güvenliliğinin Değerlendirilmesi (220S051 numaralı projeye ek bütçe)
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü), VARAN G., VARAN A., BARIŞTA İ.
2018 - 2020
2018 - 2020
Kontrollü ACPA salım sisteminin endometriyum kanserindeki CB1 reseptörü aracılı antiproliferatif ve apoptotik etkisinin araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
KORKUSUZ P. (Yürütücü), BOYACIOĞLU Ö., BİLGİÇ E., BİLENSOY E., NEMUTLU E., VARAN C.
2017 - 2020
2017 - 2020Paklitaksel yüklü siklodekstrin nanopartiküllerin antitümöral etkinliğinin araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
BİLENSOY E. (Yürütücü), Varan G., ESENDAĞLI G., Varan C.
2018 - 2019
2018 - 2019Küçük hücreli dışı akciğer adenokarsinomunda kannabinoidlerin CB reseptörleri aracılı olası antiproliferatif ve proapoptotik etkisinin araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Y.Lisans
KORKUSUZ P. (Yürütücü), Boyacıoğlu Ö., BİLGİÇ E., BİLENSOY E., VARAN C.
2017 - 2018
2017 - 2018BBBB Farmasötik Bilimler Konferansı
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü)
2017 - 2018
2017 - 2018PSWC Farmasötik Bilimler Dünya Kongresi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü)
2017 - 2017
2017 - 2017PEG-PCL nanopartiküllerin antitümöral etkinliği üzerine çalışmalar
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü)
2016 - 2017
2016 - 201713. Türkiye Eczacılık Kongresi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü)
2016 - 2017
2016 - 2017
Paklitaksel yüklü polikatyonik siklodekstrin nanopartiküllerin kanser tedavisi için hücresel etkileşim ve tümöral penetrasyon özelliklerinin araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü), VARAN G.
2015 - 2017
2015 - 2017Sefiksimin Düşük Çözünürlük ve Permeabilitesinin Siklodekstrin Türevi Kullanılarak Artırılması Üzerine İn Vivo Çalışmalar
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ÇALIŞ S. (Yürütücü), BİLENSOY E., İSKİT A. B., ÇELEN N.
2016 - 2016
2016 - 2016Kompleks İlaçlarda Bilim ve Ruhsatlandırmada Gelişmeler
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü)
2016 - 2016
2016 - 2016Paklitaksel Yüklü Folat-Konjuge Amfifilik Siklodekstrin Nanopartiküllerin Tümöre Spesifik Taşınımı ve İn Vitro-İn Vivo Değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Doktora
BİLENSOY E. (Yürütücü), ERDOĞAR N.
2016 - 2016
2016 - 2016Nanoilaçlar ve nanobenzerler: güncel regülasyonlar ve pazar durumu
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü)
2015 - 2016
2015 - 2016Siklodekstrinlerin İlaç Taşıyıcı Sistem Olarak Kullanımı
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü)
2015 - 2016
2015 - 2016Tamoksifenin Biyoyararlanımın Araştırılması ve Elektrokimyasal Tayini
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü), ABACI S., YAMAN Y. T.
2015 - 2015
2015 - 2015
Kanser tedavisinde nanopartiküllerin in vitro ve in vivo değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
BİLENSOY E. (Yürütücü)